CORONAVIRUS (COVID-19) Notice for all patients and visitors.
We are a clinician-led organisation where patient education and support services are initiated by the very people who treat breast cancer patients every day.
Your donation will help us enhance breast cancer treatment and care, and increase survival rates.
We began in 2009 with a vision to provide high quality care while conducting research that would deliver the most advanced treatments and save lives.
BCRC-WA conducts research into breast cancer treatment and care that underpins the treatment we provide to our patients.
PBCI will help us continue to reshape the future of breast cancer – offering world class treatment, care and support to patients and their families.
Click here to refer to the Glossary
Early Breast Cancer
(t-dxd vs. t-dm1 in high-risk her2-positive patients with residual invasive breast cancer following neoadjuvant therapy)
Locally Advanced or Metastatic Breast Cancer
(IV trastuzumab if applicable)
In Phase 1b, there are three arms to the study. All participants will receive study drug with or without approved oral drugs or IV trastuzumab as applicable. You will know what treatment you are receiving.
Oral (amcenestrant, palbociclib, letrozole) and subcutaneous (goserelin)